David Matheson
5PUBLICATIONS
61CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Jul 25, 2022
Docetaxel for Nonmetastatic Prostate Cancer: Long-Term Survival Outcomes in the STAMPEDE Randomized Controlled Trial.Nicholas D James, Fiona C Ingleby, Noel W Clarke
|Jun 07, 2022
Radiotherapy to the prostate for men with metastatic prostate cancer in the UK and Switzerland: Long-term results from the STAMPEDE randomised controlled trial.Chris C Parker, Nicholas D James, Christopher D Brawley
|Jun 02, 2022
Cost-utility analysis of adding abiraterone acetate plus prednisone/prednisolone to long-term hormone therapy in newly diagnosed advanced prostate cancer in England: Lifetime decision model based on STAMPEDE trial data.Caroline S Clarke, Rachael M Hunter, Andrea Gabrio
|Apr 12, 2022
Abiraterone acetate plus prednisolone for metastatic patients starting hormone therapy: 5-year follow-up results from the STAMPEDE randomised trial (NCT00268476).Nicholas D James, Noel W Clarke, Adrian Cook
|Nov 10, 2021
Quality of Life in Men With Prostate Cancer Randomly Allocated to Receive Docetaxel or Abiraterone in the STAMPEDE Trial.Hannah L Rush, Laura Murphy, Alicia K Morgans
Pageof 1
Frequent Collaborators
5 joint publications
Nicholas D James
5 joint publications
Hannah Rush
5 joint publications
Robert J Jones
5 joint publications
Matthew R Sydes
4 joint publications
Alison J Birtle
4 joint publications
Christopher D Brawley
4 joint publications
Mahesh K B Parmar
4 joint publications
Ruth E Langley
4 joint publications
Silke Gillessen
4 joint publications
Duncan Gilbert
